Table of Contents
| << Previous Issue | Jun 2023 (Vol: 2023, Issue: 6) | Next Issue >> |
- Section: Mergers & Acquisitions
-
Novartis Buys Avrobio’s Rare Disease Gene Therapy for US$87.5 M
-
Pyxis Oncology to Acquire Apexigen for US$16 M
-
Novartis to acquire Chinook Therapeutics for US$3.2 B to Bolster Kidney Disease Portfolio
-
Coherus Biosciences to Buy Surface Oncology for US$65 M
- Section: Research & Development
-
Novo Nordisk and Life Edit Therapeutics Enter Gene Editing Collaboration in Rare and Cardiometabolic Diseases
-
XtalPi Enters into Collaboration with Eli Lilly to Discover Drug Candidates Using Artificial Intelligence and Robotics Platform
PharmaDeals has now moved to a new platform (https://analyticslink.customerportal.iqvia.com). The current PharmaDeals website will be disabled from October 31, 2026. Please update your bookmarks and, if you have any issues accessing the new platform, please contact your IQVIA account manager.



RSS